New studies on retatruded, a dual activator for GLP-1 and gastric inhibitory polypeptide, demonstrate significant results in treating weight gain and type 2 glucose intolerance. Preliminary information from clinical trials reveal considerable diminutions check here in body mass and bettered glucose levels. Ongoing research is directed on long-term